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Abstract
Background—Phthalates are environmental chemicals that may play a role in the development 
of obesity. Few studies have investigated longitudinal associations between postnatal phthalate 
exposures and subsequent anthropometric measurements in children.
Methods—We collected data as part of The Breast Cancer and Environment Research Program at 
three US sites. 1,239 girls, ages 6–8 years, were enrolled in 2004–2007. We categorized baseline 
phthalate exposures, assessed from creatinine-corrected urinary concentrations of low molecular 
weight phthalate metabolites as low, <78; medium, 78-<194; and high, ≥194 μg/g creatinine and of 
high molecular weight phthalates as low, <111; medium, 111–278; and high, ≥278 μg/g creatinine. 
Anthropometric measurements were collected through 2012 (n=1,017). Linear mixed effects 
regression estimated how baseline low and high molecular weight phthalate concentrations related 
to changes in girls’ body mass index (BMI), height, and waist circumference at ages 7 through 13 
years.
Results—Low molecular weight phthalates were positively associated with gains in BMI and 
waist circumference. Predicted differences in BMI and waist circumference between girls with 
high versus low concentrations of low molecular weight phthalates increased from 0.56 (95% CI: 
−0.02, 1.1) to 1.2 (95%CI: 0.28, 2.1) kg/m2 and from 1.5 (95%CI: −0.38, 3.3) to 3.9 (95%CI: 1.3, 
6.5) cm, respectively. High molecular weight phthalates were negatively associated with height but 
only among girls who were normal weight at baseline (BMI ≤85th percentile).
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Conclusion—Phthalates, specifically low molecular weight phthalates, have small but detectable 
associations with girls’ anthropometric outcomes. Low molecular weight phthalates, showed 
stronger associations than other types of phthalates.
Introduction
Environmental chemicals may influence the development of obesity and related metabolic 
disorders.1 These chemicals are often referred to as “obesogens,” and include many 
chemicals that are ubiquitous in our daily environment;1 such as phthalates.2 Phthalates, or 
diesters of phthalic acid, are a family of man-made chemicals used in a range of consumer 
and industrial products: low molecular weight phthalates are typically found in medications 
and personal care items, such as shampoos, deodorants, and lotions, while high molecular 
weight phthalates are used in the manufacturing of flexible plastics for such purposes as 
floor and wall coverings, adhesives, medical devices, and food packaging.3–5 Exposure to 
phthalates may occur through dermal absorption, inhalation, or ingestion6 and it has been 
estimated that >98% of individuals in the United States have detectable levels of urinary 
phthalate metabolites.5
Compared to adults, children tend to have higher urine concentrations of phthalate 
metabolites.7 Children may be at increased risk of the potential adverse health effects due to 
exposures during time periods that are critical for normal growth and development. 
Laboratory evidence suggests that phthalates can disrupt normal thyroid hormone function8 
and activate peroxisome proliferator-activated receptors, which regulate lipid metabolism, 
thereby promoting fat accumulation.9,10 In children and/or adolescents, cross-sectional and 
short term follow-up studies have reported associations between specific urinary phthalate 
metabolites (or groups of metabolites) and body mass index (BMI),11–15 height,16 and waist 
circumference,11,14,15 as well as blood pressure,17 insulin resistance,18 and oxidative stress 
biomarkers.19 However, these associations have varied by age group, sex, race/ethnicity, and 
body size and may have resulted from reverse causation.
In this study, we investigated the longitudinal associations between urinary phthalate 
concentrations during childhood and subsequent body size measurements in a multi-ethnic 
cohort of elementary school-aged girls over an approximate 6 year follow-up period. To our 
knowledge, there are currently few similar studies in children.
Methods
Data were collected as part of The Breast Cancer and Environment Research Project, a 
longitudinal study with a primary objective of investigating environmental exposures and 
onset of puberty in girls. Data collection occurred at three sites: 1) Mount Sinai School of 
Medicine (MSSM), which recruited in East Harlem, New York; 2) Cincinnati Children’s 
Hospital/University of Cincinnati (Cincinnati), which recruited in the Cincinnati 
metropolitan area and the Breast Cancer Registry of Greater Cincinnati; and 3) the Kaiser 
Permanente Northern California/University of California San Francisco (KPSF), which 
recruited from Kaiser members born and still residing in the San Francisco Bay Area. 
Eligibility included age (6–8 years), female sex, and no underlying endocrine medical 
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conditions; additionally, at MSSM, eligibility required black or Hispanic race/ethnicity. 
Descriptions of the study and recruitment process are detailed elsewhere.20 The study was 
approved by the institutional review board at each site and the Centers for Disease Control 
and Prevention (CDC). A total of 1239 girls were enrolled and had baseline data collected 
during 2004–2007. For this analysis, 1017 (82%) girls had at least 3 anthropometric 
measurements collected during the study period (baseline through 2012, n=168 missing) and 
baseline urinary biomarker measurements (n=54 missing); the last visit occurred when girls 
were on average 14 years old (range, 11–16 years).
Urinary Phthalate Metabolite Measurements
At baseline, each girl provided a spot urine sample. Samples were analyzed at the National 
Center for Environmental Health at the CDC. Laboratory analytic methods and quality 
control procedures have been published.21 Briefly, the multi-rule quality control system was 
followed at the CDC to monitor performance, based on analysis of low- and high- 
concentration pools;22 batches were rerun or rejected if criteria are not met. In addition, an 
external quality control pool interspersed with samples was included (n=101). The 
coefficient of variation of this pool was <10% for six analytes with concentrations above 10 
ug/L and <21% for 3 analytes at 5–7 ug/L. Urinary concentrations were obtained for 
creatinine and nine metabolites most frequently detected in the general US population: 
monoethyl phthalate (MEP); mono-n-butyl phthalate (MBP); mono-(3-carboxypropyl) 
phthalate (MCPP); monobenzyl phthalate (MBzP); mono-isobutyl phthalate (MiBP); mono-
(2-ethylhexyl) phthalate (MEHP); mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP); mono-
(2-ethyl-5-carboxypentyl) phthalate (MECPP); and mono-(2-ethyl-5-hydroxyhexyl) 
phthalate (MEHHP). Values below the limit of detection (LOD) were imputed as LOD/
√2.21,23
To limit multiple comparisons, we analyzed individual phthalate metabolites in molar sum 
groupings based on similar sources and biologic activities: 1) low molecular weight 
phthalates (<250 Dalton), the molar sum of MEP, MBP, and MiBP (metabolites of diethyl 
phthalate (DEP), dibutyl phthalate,(DBP), and diisobutyl phthalate (DiBP), respectively); 2) 
high molecular weight phthalates (>250 Dalton), the molar sum of MEHP, MEHHP, 
MEOHP, MECPP (metabolites of di-2-ethylhexyl (DEHP)), MCPP (metabolite of di-n-octyl 
phthalate (DnOP)), and MBzP (metabolite of benzylbutyl phthalate (BzBP)); and 3) the 
molar sum of MEHP, MEHHP, MEOHP, MECPP (metabolites of DEHP, ΣDEHP). 
Therefore, high molecular weight phthalates include ΣDEHP metabolites plus the 
metabolites MCPP and MBzP. The molar sum of low molecular weight phthalates was 
expressed as MEP (molecular weight 194); the molar sum of high molecular weight 
phthalates and ΣDEHP were expressed as MEHP (molecular weight 278).21 We corrected 
urinary phthalate metabolite concentrations for creatinine (micrograms per gram creatinine, 
μg/g creatinine, or micromoles per gram creatinine, μmol/g creatinine) to account for urine 
dilution. Girls with low (<10 mg/dl, n=12) or high (>300 mg/dl, n=1) creatinine levels were 
excluded; the sample median in the remaining girls was 92 mg/dl.
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Anthropometric and Covariate Assessments
Weight, standing height, and umbilical waist circumference were collected at baseline and at 
annual follow-up visits thereafter (measurements were collected biannually at the Cincinnati 
site) by trained interviewers using a standard protocol adapted from the National Health and 
Nutrition Examination Survey (NHANES).24 Children wore light gowns or t-shirts and no 
shoes. All measurements were taken twice and the absolute difference between them was 
calculated, if the difference exceeded the specified tolerance level per NHANES protocol 
then the measurement was repeated a third time. Measurements were averaged for analyses. 
Weight and height were used to derive body mass index (BMI, weight in kilograms divided 
by squared height in meters). Only girls with measurements for weight, height, and waist 
circumference collected three or more times during the follow-up period were included in 
analyses. The median number of measurements during the follow-up period was 7 (range, 3–
13 measurements).
Data regarding sociodemographic and other characteristics were collected via self-
completed (Cincinnati site) or interviewer-administered questionnaires, conducted in English 
or Spanish, that were completed by the girl’s caregiver (usually the mother). Race/ethnicity 
was identified as black, Hispanic, white, and Asian. Socioeconomic status was represented 
by the highest attained education level of the primary caregiver, categorized as high school 
or less, college, graduate/professional school.
Statistical Analysis
We performed statistical analyses using STATA 13 (College Station, TX). We calculated 
geometric means of concentrations of the three phthalate types - Low molecular weight 
phthalates, high molecular weight phthalates, and ΣDEHP -as baseline characteristics in the 
population. We categorized creatinine-corrected concentrations (μg/g creatinine) of each of 
the three phthalate types into three categories: low, medium, and high. For low molecular 
weight phthalates, we defined categories as: low, <78; medium, 78-<194; and high, ≥194 
μg/g creatinine. For high molecular weight phthalates and ΣDEHP, we defined categories as: 
low, <111; medium, 111–278; and high, ≥278 μg/g creatinine. These categories were based 
on the distributions within the population and roughly represent at least a two-fold increase 
in the median urinary concentration for each level within each of the three phthalate groups.
Linear mixed effects models25–27 were used to assess the relationship between Year 1 
urinary metabolite concentrations (low molecular weight phthalates, high molecular weight 
phthalates, ΣDEHP) and the girls’ BMI (kg/m2), waist circumference (cm), and height (cm) 
trajectories from ages 7 through 13 years. This age range was considered due to the smaller 
numbers of girls with anthropometric data collected at younger or older ages. Mixed effects 
models easily accommodate these data since they account for unbalanced data (unequal 
numbers of repeated measurements within girls and irregular spacing of measurements 
across time and across girls) and intra-subject correlations.28 An unstructured correlation 
matrix was specified. Models included phthalate concentration categories (low, medium, 
high), child age (centered and in years estimated to the nearest tenth of a year), child age 
squared (to allow for non-linearity), an interaction term between age and concentration 
categories, an interaction term between age squared and phthalate concentration categories 
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and an interaction term between race and age. We included interactions between phthalate 
concentration categories and age to assess the different anthropometric outcome trajectories 
by the urinary phthalate metabolite concentrations. We also used results from the mixed 
effects models to calculate predicted differences (and 95% confidence intervals) at each 
integer age in the anthropometric measures between phthalate concentration categories 
(medium versus low, high versus low, high versus medium) using the pwcompare command. 
Additional adjustment for site, caregiver education, puberty status (defined as breast stage 2 
at <9.4 years, the median age in the population),29 and season of urine collection (summer 
versus non-summer) did not substantially alter the magnitude or precision of the results and 
were not included in final models. We repeated analyses without correction for creatinine 
and these yielded similar results to those with correction; therefore, we present creatinine-
corrected models.
Based on findings from previous studies,12,14 we examined interactions by child overweight 
status at baseline, dichotomized at the 85th percentile of BMI-for-age, and by race/ethnic 
group, excluding Asians due to the small sample size (n=52). Three-way interactions (race/
ethnic group*phthalate concentration category*age and overweight status*phthalate 
concentration category*age) were tested in models at a significance level of p<0.05. Due to 
potentially high correlations between phthalate metabolites within the phthalate groupings,14 
we also examined associations of individual phthalate metabolites and anthropometric 
outcomes. Similar to the phthalate groupings, we categorized individual metabolites into 
low, medium, and high creatinine-corrected concentration categories (μg/g creatinine) to 
roughly represent at least a two-fold increase in the median urinary concentration for each 
category.
Results
We have reported sociodemographic characteristics of this population previously.20,23,29 At 
enrollment, most girls (53%) were 7 years of age (Table 1). Proportions of black, white, and 
Hispanic girls were similar, while Asians made up only 5% of the population. 
Approximately half of the girls had caregivers with higher than a high school education 
(Table 1). Mean urinary phthalate concentrations did not vary much across the selected 
sociodemographic characteristics with some exceptions: concentrations of low molecular 
weight phthalates, high molecular weight phthalates, and ΣDEHP were higher among girls at 
the MSSM site and among girls with caregivers who did not graduate from high school. 
Additionally, low molecular weight phthalate concentrations tended to be higher for Black 
and Hispanic girls and for samples collected during summer months (Table 1).
There was no evidence of an interaction of phthalate metabolites with girls’ race/ethnicity. 
The association between high molecular weight phthalates and height differed by baseline 
overweight (three-way interaction, p=0.03); therefore, these analyses were stratified by 
baseline overweight status.
Low Molecular Weight Phthalates
Low molecular weight phthalates were positively associated with changes in girls’ BMI and 
waist circumference from ages 7 to 13 years (Table 2 and Figure). Compared to girls with 
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low or medium baseline concentrations of low molecular weight phthalates, those with high 
concentrations had greater predicted differences in BMI and waist circumference at baseline; 
these differences increased and became stronger as girls aged (Table 2 and Figure 1). For 
example, the predictive difference in BMI increased from 0.56 kg/m2 (95% CI: −0.02, 1.1) 
to 1.2 kg/m2 (95% CI: 0.28, 2.1) and the difference in waist circumference increased from 
1.5 cm (95% CI: −0.38, 3.3) to 3.9 cm (95% CI: 1.3, 6.5) cm (Table 2). For high versus 
medium concentrations of low molecular weight phthalates, predicted differences in BMI 
were not strong at any age, but predicted differences in waist circumference increased with 
age, from 0.65 cm (95% CI: −0.83, 2.1) to 2.9 cm (95%CI: 0.81, 5.0) (Table 2). There were 
no associations observed when comparing girls with medium concentrations of low 
molecular weight phthalates to those with low concentrations. Associations of the individual 
low molecular weight phthalate metabolites, MEP, MBP, and MiBP, with BMI and waist 
circumference were consistent with those for low molecular weight phthalates. Low 
molecular weight phthalates were weakly, negatively associated with height differences and 
the majority of predicted differences in height between exposure categories were small 
(eTables 1–3).
High Molecular Weight Phthalates
No associations were observed for high molecular weight phthalates or ΣDEHP with BMI or 
waist circumference differences. Among individual metabolites, positive associations were 
observed for MECPP, MEOHP, MEHHP, and MBzP, while negative associations were 
observed for MCPP and MEHP; however, most of the associations were weak (eTables 4–9). 
High molecular weight phthalates were negatively associated with height but only among 
girls who were normal weight at baseline (BMI ≤85th percentile) (Table 3). Girls with 
medium and high concentrations of high molecular weight phthalates were shorter at 
baseline and had smaller predicted differences in height gains over the study period than 
those with low concentrations of high molecular weight phthalates (Table 3). From ages 7–
13 years, predicted differences in height for normal weight girls with medium concentrations 
of high molecular weight phthalates were less than for similar girls with low concentrations, 
ranging from −1.3 (95% CI: −2.5, −0.20) to −1.7 (95% CI: −3.0, −0.26) cm between ages 7–
13 years (Table 3). Predicted differences in height among normal weight girls with high 
versus low concentrations of high molecular weight phthalates progressively increased from 
−1.3 (95% CI: −2.5, −0.20) to −2.2 (95% CI: −3.7, −0.69) cm (Table 3). There were no 
associations observed when comparing girls with high versus medium concentrations of 
high molecular weight phthalates. ΣDEHP was negatively associated with height but 
predicted differences between exposure groups were weak. Associations of the individual 
high molecular weight phthalate metabolites were consistent with those for high molecular 
weight phthalates, with strong associations observed for MBzP, MCPP, MEHP, and MECPP 
(eTables 10–16).
Discussion
In this longitudinal, prospective study of a multi-ethnic population of elementary school-
aged girls recruited from three diverse sites in the United States, baseline urinary 
concentrations of phthalate metabolites were associated with body size measurements 
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through 13 years of age, but varied by high or low molecular weight phthalates and the 
specific measurement. Low molecular weight phthalates were positively associated with 
BMI and waist circumference. Compared to girls with low concentrations of low molecular 
weight phthalate, girls with high concentrations of low molecular weight phthalates had 
higher baseline BMI and waist circumferences and increasing predicted differences in these 
measurements across the study period. High molecular weight phthalates were negatively 
associated with height but only among girls who were normal weight at baseline. Observed 
associations with low molecular weight phthalates and high molecular weight phthalates 
were generally consistent for each of their respective individual phthalate metabolites.
Goodman et al recently performed an extensive review of studies evaluating associations 
between postnatal phthalate concentrations and body size measures,2 concluding that there 
was weak evidence for associations among children. A majority of the studies were cross-
sectional and used data from NHANES, spanning 1999–2010. Among adolescent girls (12–
19 years) in NHANES 1999–2002, BMI and waist circumference increased across quartiles 
of MEP (a low molecular weight phthalate metabolite) and decreased across quartiles of 
MEHP (a DEHP metabolite) but there were no associations among younger children (6–11 
years) or adolescent boys.11 Low molecular weight phthalates were associated with an 
approximate 20% increased odds of overweight and obesity and 0.09 SD unit increase in 
BMI z-score among non-Hispanic black children (6–19 years), but not children of other 
race/ethnic groups in NHANES 2003–2008.12 Positive associations were also reported for 
low molecular weight phthalates and obesity among boys but not girls (6–19 years) in 
NHANES 2007–2010.13 The odds of obesity were three- to five times greater among boys in 
the higher quartiles of low molecular weight phthalate urinary concentrations compared to 
those in the lowest quartile. Lastly, in a cross-sectional study of Chinese children (8–15 
years), low molecular weight phthalates, high molecular weight phthalates, and ΣDEHP 
were positively associated with BMI and waist circumference.15
Two cohort studies, using prospectively collected data, also examined associations between 
urinary phthalate concentrations and body size measurements, including height. Among 
non-Hispanic black and Hispanic children (ages 6–8 years) recruited for the Growing Up 
Healthy Study in East Harlem, New York (which included some girls from the MSSM site in 
the current study population), dose-response relationships across quartiles of low molecular 
weight phthalate and MEP with BMI and waist circumference measured one year later were 
found for overweight (BMI>=85th percentile) girls only.14 Negative associations were 
observed for MBP (a low molecular weight phthalate metabolite) and MCPP (a high 
molecular weight phthalate metabolite) with height in girls, but not boys. In a study of 
Danish children (ages 4–9 years), ΣDEHP was negatively associated with height, defined as 
the gain in height during the previous 1.5 years.16
Although the results of previous studies are based on cross-sectional or short-term follow-up 
data and have varied by age, sex, race/ethnicity, and overweight status, they suggest a link 
between phthalates exposure and body size in children and share commonalities with the 
results of the present study. Across all studies (including this one), low molecular weight 
phthalate metabolites, specifically MEP and MBP, were associated with higher BMI, waist 
circumference, and/or odds of obesity. Among the few studies that considered height, greater 
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high molecular weight phthalate and/or ΣDEHP metabolite categories were associated with 
shorter stature. Similar to other studies,12–14 we found no association between high 
molecular weight phthalate and/or ΣDEHP and adiposity measures, but we observed both 
negative and positive associations among their individual metabolites. For example, there 
was a negative association between MEHP and BMI/waist circumference, which was also 
previously reported for adolescent girls.11
There are uncertainties regarding phthalate concentrations that may explain some of the 
differences in findings among studies. It is possible that not all phthalate metabolites within 
the same molecular weight grouping (i.e., high or low) have the same biologic actions or 
potencies, as was found in the current study for high molecular weight phthalate metabolites 
and BMI/waist circumference, which makes it difficult to discern associations when 
grouped. Sources and magnitude of exposures to individual phthalates also tend to vary by 
age and other socio-demographic characteristics within and across populations30 and may 
lack the necessary variation within specific populations to detect associations if they exist. 
Additionally, there are several potential biologic mechanisms underlying associations 
between phthalates and body size8,9 that may be linked to some of the previously observed 
differences by sex and BMI.
The most plausible mechanism for associations, specifically for body weight and adiposity 
measures, is that phthalates interfere with peroxisome-proliferator activated receptors, which 
are involved in the metabolism of fat, carbohydrates, and protein.9 Generally speaking, 
phthalates may bind to these receptors, altering metabolic processes and stimulating 
adipogenesis and the accumulation of adipose tissue.9 Some phthalates also have anti-
androgenic properties and are associated with lower testosterone levels and a higher 
estrogen/androgen ratio,13 which may explain some of the sex differences reported 
previously. Lastly, phthalates have disruptive effects on thyroid function8 and insulin-like 
growth factor-1 (IGF-1).16,16 Negative associations of phthalates with thyroid hormone, 
IGF-1, and height in children have been reported.16 In the current study, a negative 
association between high molecular weight phthalates and height was observed only among 
girls who were normal weight at baseline. Obese children have higher levels of IGF-1 and 
accelerated height velocity during the pre-pubertal years compared to normal weight 
children;31 therefore, it is possible that the negative association between high molecular 
weight phthalates and height is blunted in obese children.
In the review by Goodman et al.,2 common limitations in the literature that may explain 
inconsistencies in findings were discussed. A main limitation is that the majority of studies 
were based on cross-sectional data using one-time urine measurements as proxies for long-
term phthalate exposure. In the current study, we were able to address temporality by using 
early childhood phthalate concentrations and subsequently collected annual measurements 
of weight, height, and waist circumference through early adolescence. BMI and waist 
circumference are good predictors of subcutaneous and visceral fat, respectively,32 as well as 
metabolic-related adverse health outcomes.33 Waist circumference, in particular, is 
associated with insulin resistance, hypertension, and cardiovascular disease risk factors in 
children.33,34 Similar to previous studies, we were limited to one-time urine measurements 
for estimation of exposure to phthalates, which are short-lived chemicals in the body and 
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possibly episodic in nature. However, they have shown acceptable intra-individual variability 
over more than a year and are likely to be reasonably stable over time for the purposes of 
ranking.35,36 It is not clear if and how exposure misclassification would bias the observed 
results, especially if the associations between phthalate exposures and childhood growth 
vary with age. If exposure to phthalates increases throughout childhood/adolescence and the 
associations are assumed to be consistent throughout this growth period, then the observed 
associations reported here may be attenuated. Other limitations are related to differences in 
study populations and phthalate exposure assessment. In the current study, the sample was 
multi-ethnic but limited to girls, so we were unable to examine any potential interactions by 
sex.
Conclusions
Urinary concentrations of phthalate metabolites in girls were associated with body size 
measurements from ages 7–13 years. Low molecular weight phthalate concentrations were 
positively associated with BMI and waist circumference in all girls, while high molecular 
weight phthalate concentrations were negatively associated with height among normal 
weight girls. These results suggest that phthalates may have small but detectable associations 
with girls’ anthropometric outcomes. Low molecular weight phthalates are of particular 
interest as potential environmental obesogens. Additional longitudinal studies with multiple 
repeated phthalate measurements throughout childhood and adolescence and diverse study 
populations are necessary to confirm these findings.
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Figure 1. 
Anthropometric measurements and low molecular weight phthalate concentrations, by 
baseline concentration, over time. Predicted BMI (A) and waist circumference (B) 
trajectoriesa from 7–13 years (n=1017) among girls with low (dashed-diamonds), medium 
(line-squares), and high (dotted-triangles)
a
 Molecular weight phthalate concentrations, in umol/g creatinine: low (>78), medium (78–
<194), high (>=194)
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